ROR1 and diabetes mellitus: Although no mutations in ROR1 have been found in any human disease yet, numerous studies demonstrated aberrant expression patterns of ROR1 in many types of diseases in recent years, which made ROR1 an attractive therapeutic target in malignancies, ischemia, and diabetes (16–18), leading to a growing interest in studying ROR1 signaling and targeted therapies against ROR1 (15).